JLE

European Journal of Dermatology

MENU

Susceptibility of epithelial tumour cell lines to hyperthermia Volume 28, numéro 5, September-October 2018

  • [1] Hegyi G., Szigeti G.P., Szasz A. Hyperthermia versus oncothermia: cellular effects in complementary cancer therapy. Evid Based Complement Alternat Med. 2013;2013:672873.
  • [2] Datta N.R., Rogers S., Klingbiel D. Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses. Int J Hyperthermia. 2016;32:809-821.
  • [3] Soria F., Allasia M., Oderda M., Gontero P. Hyperthermia for non-muscle invasive bladder cancer. Expert Rev Anticancer Ther. 2016;16:313-321.
  • [4] Gao S., Zheng M., Ren X., Tang Y., Liang X. Local hyperthermia in head and neck cancer: mechanism, application and advance. Oncotarget. 2016;7:57367-57378.
  • [5] Wang H.X., Yang Y., Guo H. HSPB1 deficiency sensitizes melanoma cells to hyperthermia induced cell death. Oncotarget. 2016;7:67449-67462.
  • [6] Takahashi S., Masahashi T., Maie O. Local thermotherapy in sporotrichosis. Hautarzt. 1982;32:525-528.
  • [7] Gao X.H., Gao D., Sun X.P. Non-ablative controlled local hyperthermia for common warts. Chin Med J (Engl). 2009;122:2061-2063.
  • [8] Huo W., Gao X.H., Sun X.P. Local hyperthermia at 44 degrees C for the treatment of plantar warts: a randomized, patient-blinded, placebo-controlled trial. J Infect Dis. 2010;201:1169-1172.
  • [9] Mouratidis P.X., Rivens I., Ter Haar G. A study of thermal dose-induced autophagy, apoptosis and necroptosis in colon cancer cells. Int J Hyperthermia. 2015;31:476-488.
  • [10] Vig M., Kinet J.P. Calcium signaling in immune cells. Nat Immunol. 2009;10:21-27.
  • [11] Cahalan M.D. STIMulating store-operated Ca(2+) entry. Nat Cell Biol. 2009;11:669-677.
  • [12] Xiao B., Coste B., Mathur J., Patapoutian A. Temperature-dependent STIM1 activation induces Ca(2)+ influx and modulates gene expression. Nat Chem Biol. 2011;7:351-358.
  • [13] Mancarella S., Wang Y., Gill D.L. Signal transduction: STIM1 senses both Ca(2)+ and heat. Nat Chem Biol. 2011;7:344-345.
  • [14] Umemura M., Baljinnyam E., Feske S. Store-operated Ca2+ entry (SOCE) regulates melanoma proliferation and cell migration. PLoS One. 2014;9:e89292.
  • [15] Chen Y.F., Chiu W.T., Chen Y.T. Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis. Proc Natl Acad Sci USA. 2011;108:15225-15230.
  • [16] Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 1998;281:1309-1312.
  • [17] Honda H., Kondo T., Zhao Q.L., Feril L.B. Jr., Kitagawa H. Role of intracellular calcium ions and reactive oxygen species in apoptosis induced by ultrasound. Ultrasound Med Biol. 2004;30:683-692.
  • [18] Fajardo L.F., Egbert B., Marmor J., Hahn G.M. Effects of hyperthermia in a malignant tumor. Cancer. 1980;45:613-623.
  • [19] Tamm I., Wang Y., Sausville E. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 1998;58:5315-5320.
  • [20] Branca M., Giorgi C., Santini D. Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. Am J Clin Pathol. 2005;124:113-121.
  • [21] Frost M., Jarboe E.A., Orlicky D. Immunohistochemical localization of survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma. Am J Clin Pathol. 2002;117:738-744.
  • [22] Honegger A., Leitz J., Bulkescher J., Hoppe-Seyler K., Hoppe-Seyler F. Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells. Int J Cancer. 2013;133:1631-1642.
  • [23] Borbely A.A., Murvai M., Konya J. Effects of human papillomavirus type 16 oncoproteins on survivin gene expression. J Gen Virol. 2006;87:287-294.
  • [24] Saxena A., Yashar C., Taylor D.D., Gercel-Taylor C. Cellular response to chemotherapy and radiation in cervical cancer. Am J Obstet Gynecol. 2005;192:1399-1403.
  • [25] Milrot E., Jackman A., Kniazhanski T. Methyl jasmonate reduces the survival of cervical cancer cells and downregulates HPV E6 and E7, and survivin. Cancer Lett. 2012;319:31-38.